National Bank Of Canada Novavax Inc Transaction History

National Bank Of Canada

$57.5 Billion
Q1 2024

A detailed history of National Bank Of Canada transactions in Novavax Inc stock. As of the latest transaction made, National Bank Of Canada holds 388,044 shares of NVAX stock, worth $4.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

388,044

Previous 2,215 17418.92%

Holding current value

$4.91 Million

Previous $10,000 18440.0%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.76 - $6.02 $1.45 Million - $2.32 Million	385,829 Added 17418.92%	388,044 $1.85 Million
Q4 2023 Feb 06, 2024	SELL	$4.8 - $7.67 $299,246 - $478,170	-62,343 Reduced 96.57%	2,215 $10,000
Q3 2023 Oct 10, 2023	SELL	$6.81 - $9.74 $5.34 Million - $7.64 Million	-784,287 Reduced 92.39%	64,558 $467,000
Q2 2023 Jul 26, 2023	BUY	$6.67 - $9.52 $3.37 Million - $4.82 Million	505,970 Added 147.57%	848,845 $6.31 Million
Q1 2023 Apr 12, 2023	SELL	$5.76 - $12.48 $807,782 - $1.75 Million	-140,240 Reduced 29.03%	342,875 $2.38 Million

Q4 2022 Jan 24, 2023	BUY	$8.86 - $25.04 $4.27 Million - $12.1 Million	481,780 Added 36088.39%	483,115 $0
Q3 2022 Oct 13, 2022	BUY	$18.2 - $76.12 $3,276 - $13,701	180 Added 15.58%	1,335 $24,000
Q2 2022 Jul 28, 2022	SELL	$36.28 - $75.29 $77,494 - $160,819	-2,136 Reduced 64.9%	1,155 $59,000
Q1 2022 May 05, 2022	BUY	$69.73 - $142.9 $129,000 - $264,365	1,850 Added 128.38%	3,291 $242,000
Q4 2021 Jan 24, 2022	BUY	$134.56 - $217.97 $193,900 - $314,094	1,441 New	1,441 $206,000

Others Institutions Holding NVAX

# of Institutions

241

Shares Held

76.1M

Call Options Held

5.06M

Put Options Held

7.19M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $990M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Account

National Bank Of Canada Novavax Inc Transaction History